Pages that link to "Q37971873"
Jump to navigation
Jump to search
The following pages link to Targeting the endothelin axis in prostate carcinoma (Q37971873):
Displayed 16 items.
- Evolving landscape and novel treatments in metastatic castrate-resistant prostate cancer (Q27010542) (← links)
- Overexpression of LAPTM4B-35: a novel marker of poor prognosis of prostate cancer (Q28541215) (← links)
- Clinical pharmacology of an atrasentan and docetaxel regimen in men with hormone-refractory prostate cancer (Q29006772) (← links)
- Recent advances in bone-targeted therapies of metastatic prostate cancer (Q33703763) (← links)
- Clinical significance of NUCB2 mRNA expression in prostate cancer (Q37116462) (← links)
- Prognostication of prostate cancer based on NUCB2 protein assessment: NUCB2 in prostate cancer (Q37367755) (← links)
- The endothelin axis in head and neck cancer: a promising therapeutic opportunity? (Q38129921) (← links)
- Bone microenvironment-targeted manipulations for the treatment of osteoblastic metastasis in castration-resistant prostate cancer (Q38136271) (← links)
- New therapeutic targets for cancer bone metastasis (Q38473066) (← links)
- Activation of ETA Receptor by Endothelin-1 Induces Hepatocellular Carcinoma Cell Migration and Invasion via ERK1/2 and AKT Signaling Pathways (Q38824920) (← links)
- Skeletal complications in cancer patients with bone metastases (Q38917438) (← links)
- Research on tumorigenicity of cinnamaldehyde in melanoma cell lines and its mechanism (Q39014105) (← links)
- The efficacy of cetuximab in a tissue-engineered three-dimensional in vitro model of colorectal cancer (Q42044314) (← links)
- The prognostic value of Smad4 mRNA in patients with prostate cancer (Q44984281) (← links)
- Mesenchymal Stromal Cells: Emerging Roles in Bone Metastasis. (Q55235695) (← links)
- Incidence and risk of hypertension with ramucirumab in cancer patients: a meta-analysis of published studies (Q86776509) (← links)